Although metabolic syndrome is associated with higher PsA disease activity, it is not associated with higher PsA-related ...
Psoriatic arthritis (PsA) is a chronic inflammatory condition that affects approximately 112 per 100,000 adults worldwide. It ...
Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.
Bristol-Myers Squibb (BMY) stock in focus as psoriasis drug Sotyktu shows promising results in treating psoriatic arthritis ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...
Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...
Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research.
Dr. Ariz Sheikh - By following these strategies, you can better manage morning stiffness and improve your comfort and ...
The following is a summary of “Potentially Avoidable Emergency Department Utilization by Persons With Psoriatic Arthritis and ...
3h
Money Talks News on MSNIf You Have Arthritis, This New Makeup Brand Is for YouTilt is a new makeup brand with products designed to make beauty accessible to everyone. It’s the first beauty brand and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results